Home  

Enter a class name or drug name above to search the database.

Hematologic Activity Alteration [PE]

NDC Number Brand Name Generic Name Labeler Dosage Form DEA Schedule Marketing Start Date
0615-8511 Pentoxifylline Pentoxifylline NCS HealthCare of KY, LLC dba Vangard Labs TABLET, EXTENDED RELEASE 2024-01-15
0904-5448 PENTOXIFYLLINE PENTOXIFYLLINE Major Pharmaceuticals TABLET, EXTENDED RELEASE 1999-06-10
16571-856 Pentoxifylline Pentoxifylline Rising Pharma Holdings, Inc. TABLET, EXTENDED RELEASE 2024-06-11
60505-0033 PENTOXIFYLLINE PENTOXIFYLLINE Apotex Corp. TABLET, EXTENDED RELEASE 1999-06-10
63629-2910 PENTOXIFYLLINE PENTOXIFYLLINE Bryant Ranch Prepack TABLET, EXTENDED RELEASE 1999-06-10
68071-4532 Pentoxifylline Pentoxifylline NuCare Pharmaceuticals,Inc. TABLET, EXTENDED RELEASE 2014-08-22
70954-668 Pentoxifylline Pentoxifylline ANI Pharmaceuticals, Inc. TABLET, EXTENDED RELEASE 2024-01-15
71335-2586 Pentoxifylline Pentoxifylline Bryant Ranch Prepack TABLET, EXTENDED RELEASE 2024-06-11
72162-2113 PENTOXIFYLLINE PENTOXIFYLLINE Bryant Ranch Prepack TABLET, EXTENDED RELEASE 1999-06-10

 Physiological Effect (PE) Classification 

Loading full table content...